Effectiveness of Glucose Monitoring Systems Modified for the Visually Impaired

Bernbaum, Marla; Albert, Stewart G.; Brusca, Stephanie; McGinnis, Joan; Miller, Deborah; Hoffmann, Joseph W.; Mooradian, Arshag D.

doi:10.2337/diacare.16.10.1363

Cited by 4 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Assay of serum glucose, insulin, and adiponectin Serum glucose levels were determined using a glucose analyzer [15]. Serum levels of insulin were determined using ELISA kits (Shibayagi Co., Ltd, Japan).…”

Section: Fat-cell Sizementioning

confidence: 99%

Adiponectin mRNA Levels in Parametrial Adipose Tissue and Serum Adiponectin Levels are Reduced in Mice During Late Pregnancy

et al. 2004

View full text Add to dashboard Cite

Adiponectin, a fat-derived factor, is downregulated in insulin resistance and obesity; insulin resistance has been demonstrated during late pregnancy in both humans and in rodents. The present study examines the physiological change of adiponectin gene expression as well as the circulating levels of adiponectin during pregnancy. We examined the relative quantity of adiponectin mRNA produced in the adipose tissues of pregnant compared to virgin mice. We also measured serum adiponectin levels and parametrial adipocyte size in mice throughout pregnancy. Adiponectin mRNA was significantly reduced by 74 +/- 8 % and 63 +/- 4 % at days 15 and 18 of pregnancy, respectively, compared to virgin mice. Serum adiponectin concentration decreased on days 15 (30.7 +/- 8.5 microg/ml) and 18 (27.9 +/- 8.7 microg/ml) of pregnancy, and the values were significantly lower than that of virgin mice (56.8 +/- 6.6 microg/ml). Parametrial adipocytes from mice on days 15 and 18 of pregnancy were significantly larger than in virgin mice or during early pregnancy. Fat-cell size was closely correlated to degradation of adiponectin gene expression and serum adiponectin levels. These results suggest that changes of adiponectin expression affect metabolic status in pregnant mice.

show abstract

Section: Fat-cell Sizementioning

confidence: 99%

Adiponectin mRNA Levels in Parametrial Adipose Tissue and Serum Adiponectin Levels are Reduced in Mice During Late Pregnancy

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Two reports have suggested that, with extensive instruction, subjects may be able to use SMBG with satisfactory results. 55,56 This entailed using adapted devices with tactile and auditory feedback features.…”

Section: Other Factors Influencing Reliability Patient Factorsmentioning

confidence: 99%

Monitoring blood glucose control in diabetes mellitus: a systematic review.

Coster¹,

Gulliford

Seed

et al. 2000

Health Technology Assessment

205

View full text Add to dashboard Cite

Health Technology Assessment is indexed in Index Medicus/MEDLINE and Excerpta Medica/ EMBASE. Copies of the Executive Summaries are available from the NCCHTA website (see overleaf). NHS R&D HTA ProgrammeT he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources.The Standing Group on Health Technology advises on national priorities for health technology assessment. Six advisory panels assist the Standing Group in identifying and prioritising projects. These priorities are then considered by the HTA Commissioning Board supported by the National Coordinating Centre for HTA (NCCHTA).This report is one of a series covering acute care, diagnostics and imaging, methodology, pharmaceuticals, population screening, and primary and community care. It was identified as a priority by the Diagnostics and Imaging Panel and funded as project number 96/10/03.The views expressed in this publication are those of the authors and not necessarily those of the Standing Group, the Commissioning Board, the Panel members or the Department of Health. The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for the recommendations for policy contained herein. In particular, policy options in the area of screening will be considered by the National Screening Committee. This Committee, chaired by the Chief Medical Officer, will take into account the views expressed here, further available evidence and other relevant considerations.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. Criteria for inclusion in the HTA monograph seriesReports are published in the HTA monograph series if (1) they have resulted from work either prioritised by the Standing Group on Health Technology, or otherwise commissioned for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the referees and editors.

show abstract

“…Only a few research studies have been published about accessible DSM tools and techniques used by visually impaired people. [2][3][4][5][6][7][8] However, both health professional and lay publications describe numerous DSM tools and techniques that are accessible to and used by this population. [9][10][11][12][13][14][15][16] The definition of "visual impairment" used in this article is inability to read regular print, which is functionally similar to the definition used by the Centers for Disease Control and Prevention: inability to see well when wearing glasses or contact lenses.…”

Section: Introductionmentioning

confidence: 99%

A Comparison of Dosing Accuracy: Visually Impaired and Sighted People Using Insulin Pens

Williams

Schnarrenberger

2010

J Diabetes Sci Technol

View full text Add to dashboard Cite

Effectiveness of Glucose Monitoring Systems Modified for the Visually Impaired

Abstract: In addition to laboratory assessments of glucose meters, monitoring systems designed for the visually impaired must include adequate tactile and audible feedback features to allow for the acquisition and placement of appropriate blood samples.

Cited by 4 publications

References 2 publications

Adiponectin mRNA Levels in Parametrial Adipose Tissue and Serum Adiponectin Levels are Reduced in Mice During Late Pregnancy

Adiponectin mRNA Levels in Parametrial Adipose Tissue and Serum Adiponectin Levels are Reduced in Mice During Late Pregnancy

Monitoring blood glucose control in diabetes mellitus: a systematic review.

A Comparison of Dosing Accuracy: Visually Impaired and Sighted People Using Insulin Pens

Contact Info

Product

Resources

About